Central serous chorioretinopathy or choroidopathy (CSC) typically affects young to middle age males who have been described as having type A behavior. Although CSC is often self limited, some patients have persistent CSC, others have multiple bouts and some require treatment with laser or PDT. There is some evidence that patients with a history of CSC have a higher incidence of CNVM and occasionally develop large disciform scars. Since effective anti-VEGF treatments are now available for early CNVM, the timely detection of the transition of dry to wet maculopathy is imperative.